Apr 14, 2025 18:19
IRWD - Ironwood Pharmaceuticals, Inc. - Class A
Day | 1m | 10m | 60m | PreMarket | Market | AfterHours | Gap |
---|---|---|---|---|---|---|---|
1.46 0.08 (5.48%) | 0.0 (0.0%) | 0.03 (1.99%) | 0.02 (1.32%) | 0.08 (5.48%) | --- | -0.03 (-1.91%) | -0.01 (-0.62%) |
Ironwood Pharmaceuticals Inc is a specialty and generic drug manufacturing company that operates a human therapeutics segment. The company is focused on advancing product opportunities in areas of large unmet need, including irritable bowel syndrome with constipation, chronic idiopathic constipation, hyperuricemia associated with uncontrolled gout, uncontrolled gastroesophageal reflux disease, and vascular and fibrotic diseases. The company considers collaborative licenses, commercial agreements, and acquisition investment to be potential components of its operational growth plan for expanding its research, development, manufacturing, and marketing capabilities.
Earnings & Ratios
- Basic EPS:
- 0.15
- Diluted EPS:
- 0.14
- Basic P/E:
- 10.2667
- Diluted P/E:
- 11.0
- RSI(14) 1m:
- 73.81
- VWAP:
- 1.54
- RVol:
- 0.0069
Events
Period | Kind | Movement | Occurred At |
---|---|---|---|
1m | Price increase 1m | 1.54 +0.02 (+1.15%) | Oct 15 08:07 |
10m | Price decrease 10m | 1.49 -0.2 (-11.83%) | Oct 15 04:12 |
60m | Price increase 60m | 1.69 +0.23 (+15.75%) | Oct 15 04:11 |
Day | Price increase day | 1.69 +0.23 (+15.75%) | Oct 15 04:11 |
60m | Price decrease 60m | 1.52 -0.09 (-5.53%) | Oct 14 19:56 |
Related News
Dec 06, 2024 12:00
Jul 05, 2024 10:31
May 10, 2024 15:16
May 02, 2024 14:01
Mar 25, 2024 13:57
Mar 07, 2024 12:18
Feb 29, 2024 19:00
Feb 29, 2024 15:40
Feb 29, 2024 14:20